<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05112367</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL21_0613</org_study_id>
    <nct_id>NCT05112367</nct_id>
  </id_info>
  <brief_title>Epidemiology and Management of Pediatric Anaphylaxis and Allergy in the Pediatric Emergency Department of Montpellier</brief_title>
  <acronym>Ana-Ped</acronym>
  <official_title>Retrospective Study on the Management of Pediatric Anaphylaxis and Clinical Signs of Allergy in the Pediatric Emergency Department of Montpellier University Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anaphylaxis is a severe life-threatening reaction following exposure to an antigen. Its&#xD;
      incidence is progressively increasing in the general population over years, especially among&#xD;
      children. The diagnosis can be difficult, and recommendations for follow up and prescription&#xD;
      for an emergency kit are rarely provided after emergency visit. The Investigators will&#xD;
      evaluate the management of pediatric anaphylaxis and clinical signs of allergy in the&#xD;
      pediatric emergency department of Montpellier University Hospital&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2021</start_date>
  <completion_date type="Anticipated">June 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of the management of pediatric anaphylaxis of allergy</measure>
    <time_frame>day 1</time_frame>
    <description>Evaluation of the management of pediatric anaphylaxis of allergy in the pediatric emergency department of Montpellier University Hospital.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of the management of pediatric clinical signs evocative of allergy in the pediatric emergency department of Montpellier University Hospital.</measure>
    <time_frame>day 1</time_frame>
    <description>Evaluation of the management of pediatric clinical signs evocative of allergy in the pediatric emergency department of Montpellier University Hospital.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of an appropriate use of epinephrine</measure>
    <time_frame>day 1</time_frame>
    <description>Evaluation of an appropriate use of epinephrine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of an appropriate use of a possible follow-up of patients after the episode</measure>
    <time_frame>day 1</time_frame>
    <description>Evaluation of an appropriate use of a possible follow-up of patients after the episode</description>
  </secondary_outcome>
  <enrollment type="Anticipated">2500</enrollment>
  <condition>Anaphylaxis</condition>
  <condition>Allergy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Children consulting in the paediatric emergency department of Montpellier for suspected&#xD;
        allergy from 2016 to 2020&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Patients evaluated at the Montpellier University Hospital, Allergy Unit ;&#xD;
&#xD;
          -  Children consulting for suspected allergy from 2016 to 2020&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
        - Patients under legal protection, under guardianship or under curatorship;&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Davide CAIMMI</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Davide CAIMMI, MD</last_name>
    <phone>467336112</phone>
    <phone_ext>33</phone_ext>
    <email>davide.caimmi@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Evang√©line CLARK, doctor</last_name>
    <phone>467336107</phone>
    <email>e-clark@chu-montpellier.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Uhmontpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Davide CAIMMI, MD</last_name>
      <phone>467336112</phone>
      <phone_ext>33</phone_ext>
      <email>davide.caimmi@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 27, 2021</study_first_submitted>
  <study_first_submitted_qc>October 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 8, 2021</study_first_posted>
  <last_update_submitted>October 27, 2021</last_update_submitted>
  <last_update_submitted_qc>October 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Children</keyword>
  <keyword>Emergency</keyword>
  <keyword>Epinephrine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
    <mesh_term>Anaphylaxis</mesh_term>
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>NC</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

